Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elio Scarpini

Showing results (271-280 of 329) with videos related to

Pageof 33
Sort By:
Journal of Alzheimer'S Disease : JAD|June 29, 2011
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysisMaria Serpente, Chiara Fenoglio, Chiara Villa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 8, 2018
CSF β-amyloid predicts prognosis in patients with multiple sclerosisAnna M Pietroboni, Michela Caprioli, Tiziana Carandini, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patientsFrancesco Lescai, Chiara Pirazzini, Giuseppe D'Agostino, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2010
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's diseaseEliana Venturelli, Chiara Villa, Chiara Fenoglio, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2012
Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDIIClaudio D'Addario, Bernardo Dell'Osso, Maria Carlotta Palazzo, et al.
Molecular Neurodegeneration|February 25, 2016
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assayWendy E Heywood, Daniela Galimberti, Emily Bliss, et al.
Journal of Alzheimer'S Disease : JAD|January 12, 2010
GRN variability contributes to sporadic frontotemporal lobar degenerationDaniela Galimberti, Chiara Fenoglio, Francesca Cortini, et al.
Archives of Neurology|November 16, 2005
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer diseaseDavide Anchisi, Barbara Borroni, Massimo Franceschi, et al.
The New England Journal of Medicine|January 25, 2018
Trial of Solanezumab for Mild Dementia Due to Alzheimer's DiseaseLawrence S Honig, Bruno Vellas, Michael Woodward, et al.
Rejuvenation Research|May 10, 2011
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degenerationChiara Villa, Chiara Fenoglio, Milena De Riz, et al.
Pageof 33

Showing results (271-280 of 329) with videos related to

Sort By:
Pageof 33
Journal of Alzheimer'S Disease : JAD|June 29, 2011
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysisMaria Serpente, Chiara Fenoglio, Chiara Villa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 8, 2018
CSF β-amyloid predicts prognosis in patients with multiple sclerosisAnna M Pietroboni, Michela Caprioli, Tiziana Carandini, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patientsFrancesco Lescai, Chiara Pirazzini, Giuseppe D'Agostino, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2010
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's diseaseEliana Venturelli, Chiara Villa, Chiara Fenoglio, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2012
Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDIIClaudio D'Addario, Bernardo Dell'Osso, Maria Carlotta Palazzo, et al.
Molecular Neurodegeneration|February 25, 2016
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assayWendy E Heywood, Daniela Galimberti, Emily Bliss, et al.
Journal of Alzheimer'S Disease : JAD|January 12, 2010
GRN variability contributes to sporadic frontotemporal lobar degenerationDaniela Galimberti, Chiara Fenoglio, Francesca Cortini, et al.
Archives of Neurology|November 16, 2005
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer diseaseDavide Anchisi, Barbara Borroni, Massimo Franceschi, et al.
The New England Journal of Medicine|January 25, 2018
Trial of Solanezumab for Mild Dementia Due to Alzheimer's DiseaseLawrence S Honig, Bruno Vellas, Michael Woodward, et al.
Rejuvenation Research|May 10, 2011
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degenerationChiara Villa, Chiara Fenoglio, Milena De Riz, et al.
Pageof 33